A plug-and-play platform of ratiometric bioluminescent sensors for homogeneous immunoassays
Ni, Yan; Rosier, Bas J H M; van Aalen, Eva A; Hanckmann, Eva T L; Biewenga, Lieuwe; Pistikou, Anna-Maria Makri; Timmermans, Bart; Vu, Chris; Roos, Sophie; Arts, Remco; Li, Wentao; de Greef, Tom F A; van Borren, Marcel M G J; van Kuppeveld, Frank J M; Bosch, Berend-Jan; Merkx, Maarten
(2021) Nature Communications, volume 12, issue 1, pp. 1 - 12
(Article)
Abstract
Heterogeneous immunoassays such as ELISA have become indispensable in modern bioanalysis, yet translation into point-of-care assays is hindered by their dependence on external calibration and multiple washing and incubation steps. Here, we introduce RAPPID (Ratiometric Plug-and-Play Immunodiagnostics), a mix-and-measure homogeneous immunoassay platform that combines highly specific antibody-based detection with a
... read more
ratiometric bioluminescent readout. The concept entails analyte-induced complementation of split NanoLuc luciferase fragments, photoconjugated to an antibody sandwich pair via protein G adapters. Introduction of a calibrator luciferase provides a robust ratiometric signal that allows direct in-sample calibration and quantitative measurements in complex media such as blood plasma. We developed RAPPID sensors that allow low-picomolar detection of several protein biomarkers, anti-drug antibodies, therapeutic antibodies, and both SARS-CoV-2 spike protein and anti-SARS-CoV-2 antibodies. With its easy-to-implement standardized workflow, RAPPID provides an attractive, fast, and low-cost alternative to traditional immunoassays, in an academic setting, in clinical laboratories, and for point-of-care applications.
show less
Download/Full Text
Keywords: General Chemistry, General Biochemistry,Genetics and Molecular Biology, General Physics and Astronomy
ISSN: 2041-1723
Publisher: Nature Publishing Group
Note: Funding Information: We thank Dr. Leo van IJzendoorn and the members of the T.E.S.T. student team for help with the anti-adalumimab assay, Prof. Frank Grosveld (Erasmus MC, Rotterdam, The Netherlands) for providing access to the 47D11 and 49F1 antibodies, Dr. Maarten Broeren and Dr. Luc Derijks (Máxima Medical Center, Veldhoven, The Netherlands) for useful discussions regarding TNFα-binding therapeutic antibodies. We thank Nick Burlet for initial experiments on the CRP assay, Dr. Simone Wouters and Nick Burlet for help with the expression of the calibrator luciferase, and Pim de Vink for initial help with the thermodynamic model. This work was supported by the European Research Council, ERC starting grant (ERC-2011-StG 280255) and an ERC proof of concept grant (ERC-2016-PoC 755471), funding by the TU/e COVID19 University Fund, grants from the Netherlands Organization for Scientific Research, NWO-Take-off-1 grant (NWO, 17820), and RAAK.PRO Printing makes sense (RAAK.PRO02.066). Publisher Copyright: © 2021, The Author(s).
(Peer reviewed)